The agency submitted before Special CBI Judge Gurdeep Singh that Saxena, also the Chief Operating Officer of Elder Pharmaceuticals, had played a direct role in bribing Bansal to ensure that he does not order an SFIO inspection against his firm on charges of illegal collection of Rs 175 crore from 24,000 investors, diversion of funds to companies abroad and not giving returns on time.
While seeking bail for Saxena, known for roles in soaps "Kkusum" and "Kumkum", senior advocate K K Manan said that his client did not have any direct link with the case and there was only a disclosure statement of a co-accused.
He claimed that CBI had tapped the accused' phone but no incriminating material was found against the actor and that he was ready to join the investigation.
According to CBI, an FIR was registered against Saxena alleging that his company Elder Pharmaceuticals had bribed Bansal to ensure that he does not order an SFIO inspection on charges against him.
Saxena, who is COO and Chairman-cum Managing Director of the firm, has not been arrested by CBI which has taken into custody Bansal, middleman Vishwadeep Bansal and two more private persons.
The case emanated from complaints received by Registrar of Companies in the Ministry of Corporate Affairs from investors who had alleged that Elder Pharmaceuticals had collected over Rs 175 crore from over 24,000 investors under Companies' Acceptance of Deposits Rule, CBI has said.
The ministry had instituted an inspection by Regional Director (West) Mumbai which claimed the company had allegedly not kept 15 per cent of deposits in liquid form, accepted Rs 138 crore from other companies which was akin to accepting deposits among other acts which were against the law, it has said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
